Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly $500 million
A view of a plastic model of a stomach during an interview with Doctor Thomas Horbach, specialist in surgery, visceral surgery and nutritional medicine on Novo Nordisk, which will start selling its hugely popular obesity drug Wegovy in Germany later […]










